The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥786.95Fair value¥3,325.08Bull¥5,050.90
FairClose
52-week traded range
52W low ¥4,889.0052W high ¥6,290.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
Ezaki Glico Co.,Ltd. closed at ¥4,984.00, 49.9% above the consensus fair value of ¥3,325.08 drawn from 9 valuation models.
Financial DNA score 43/100 — Average. P/E of 63.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥5,050.90
+1.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
¥2,789.79
-44.0%
√(22.5 × EPS × BVPS)
EPS=79.12, BVPS=4371.93 · outside Graham range (P/E 63, P/B 1.1) — asset-light, treat as a rough floor
P/E Fair Value
¥1,582.40
-68.3%
EPS × 20x (sector P/E)
EPS=79.12, Sector P/E=20x
Peter Lynch (PEG)
¥1,731.15
-65.3%
EPS × Growth% (PEG = 1 is fair)
EPS=79.12, g=21.9%
EV/EBITDA
¥4,449.89
-10.7%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=28.34B
Dividend Discount (DDM)
¥1,213.73
-75.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=95.19, r=10%, g=2%
Book Value (P/B)
¥786.95
-84.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=4371.93, ROE=1.8%, g=3%, r=10%
Reverse DCF
¥4,984.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 22.7% | Historical: -21.9%
Margin of Safety
¥2,355.77
-52.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3141.03, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.